MH, D., TL, S., KJ, F., SE, F., & CA, E. (2016). Pharmacotherapy for Fragile X Syndrome: Progress to Date. Drugs, 76(4), 431. https://doi.org/10.1007/s40265-016-0542-y
Chicago Style (17th ed.) CitationMH, Davenport, Schaefer TL, Friedmann KJ, Fitzpatrick SE, and Erickson CA. "Pharmacotherapy for Fragile X Syndrome: Progress to Date." Drugs 76, no. 4 (2016): 431. https://doi.org/10.1007/s40265-016-0542-y.
MLA (9th ed.) CitationMH, Davenport, et al. "Pharmacotherapy for Fragile X Syndrome: Progress to Date." Drugs, vol. 76, no. 4, 2016, p. 431, https://doi.org/10.1007/s40265-016-0542-y.
Warning: These citations may not always be 100% accurate.